Skip to main content
SpringerLink
Log in

Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008

Leitlinien zur Therapie der chronischen und akuten Herzinsuffizienz: Was ist neu?

Commentary on the ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008

Guidelines on the treatment of chronic and acute heart failure: What is new?

  • Leitlinien
  • Published:
Der Kardiologe Aims and scope

Zusammenfassung

Von der Europäischen Gesellschaft für Kardiologie (ESC) wurde eine überarbeitete Leitlinie zur Diagnostik und Therapie der Herzinsuffizienz veröffentlicht. In dieser Leitlinie haben alle neuen Studien, die seit der letzten Version von 2005 zur Therapie der Herzinsuffizienz veröffentlich wurden, Eingang gefunden. Zudem wurden von der ESC die Leitlinien zur Therapie der chronischen und akuten Herzinsuffizienz vereint. Die wesentlichen Änderungen dieser überarbeiteten Version im Vergleich zur früheren Leitlinie der ESC und der Leitlinie der Deutschen Gesellschaft für Kardiologie (DGK) werden zusammengestellt. Eine eigenständige Leitlinie der DGK wird nur noch als Kurzfassung (Pocket-Leitlinie) erscheinen.

Abstract

The European Society of Cardiology (ESC) has published updated guidelines for the diagnosis and treatment of heart failure. The new guidelines include all new studies on the therapy of heart failure that have been published since the last version in 2005. Moreover, the ESC has combined the guidelines for the treatment of acute and chronic heart failure. Relevant changes in this updated version compared to the previous ESC guidelines and the guidelines issued by the German Society of Cardiology (DGK) are summarized. Independent updated DGK guidelines will be published as an executive summary only (pocket guideline).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Hoppe UC, Böhm M, Dietz R et al (2005) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Im Auftrag der Deutschen Gesellschaft für Kardiologie. Z Kardiol 94:488–509

    Article  PubMed  CAS  Google Scholar 

  2. Swedberg K, Cleland J, Dargie H et al (2005) Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The task force for the diagnosis and treatment of chronic heart failure of the european society of cardiology. Eur Heart J 26:1115–1140

    Article  PubMed  Google Scholar 

  3. Anker SD, Negassa A, Coats AJ et al (2003) Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361:1077–1083

    Article  PubMed  CAS  Google Scholar 

  4. Rees K, Taylor RS, Singh S et al (2004) Exercise based rehabilitation for heart failure. Cochrane database of systematic reviews (Online) 3:CD003331

    Google Scholar 

  5. Corra U, Pistono M, Mezzani A et al (2006) Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence. Circulation 113:44–50

    Article  PubMed  Google Scholar 

  6. Rutledge T, Reis VA, Linke SE et al (2006) Depression in heart failure a meta-analytic review of prevalence, intervention effects and associations with clinical outcomes. J Am Coll Cardiol 48:1527–1537

    Article  PubMed  Google Scholar 

  7. Kjekshus J, Apetrei E, Barrios V et al (2007) Rosuvastatin in older patients with systolic heart failure. N Engl J Med 357:2248–2261

    Article  PubMed  CAS  Google Scholar 

  8. GISSI-HF I (2008) Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet (in press)

  9. Cohn JN, Tognoni G for the valsartan, heart, failure, trial, investigators (2001) A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345:1667–1675

    Article  PubMed  CAS  Google Scholar 

  10. McMurray JJ, Ostergren J, Swedberg K et al (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet 362:767–771

    Article  PubMed  CAS  Google Scholar 

  11. Cleland JG, Tendera M, Adamus J et al (2006) The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 27:2338–2345

    Article  PubMed  CAS  Google Scholar 

  12. Yusuf S, Pfeffer MA, Swedberg K et al (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial. Lancet 362:777–781

    Article  PubMed  CAS  Google Scholar 

  13. Fuster V, Ryden LE, Cannom DS et al (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). Eur Heart J 27:1979–2030

    Article  PubMed  Google Scholar 

  14. Lemke B, Nowak B, Pfeiffer D (2005) Leitlinien zur Herzschrittmachertherapie. Z Kardiol 94:704–720

    Article  PubMed  CAS  Google Scholar 

  15. Vardas PE, Auricchio A, Blanc JJ et al (2007) Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 28:2256–2295

    Article  PubMed  Google Scholar 

  16. Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237

    Article  PubMed  CAS  Google Scholar 

  17. Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883

    Article  PubMed  Google Scholar 

  18. Bristow MR, Saxon LA, Boehmer J et al (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–2150

    Article  PubMed  CAS  Google Scholar 

  19. Cleland JG, Daubert JC, Erdmann E et al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539–1549

    Article  PubMed  CAS  Google Scholar 

  20. Bradley DJ, Bradley EA, Baughman KL et al (2003) Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA 289:730–740

    Article  PubMed  Google Scholar 

  21. Mebazaa A, Nieminen MS, Packer M et al (2007) Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial. JAMA 297:1883–1891

    Article  PubMed  CAS  Google Scholar 

  22. Bayram M, De Luca L, Massie MB, Gheorghiade M (2005) Reassessment of dobutamine, dopamine and milrinone in the management of acute heart failure syndromes. Am J Cardiol 96:47G–58G

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Authors
  1. U.C. Hoppe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Böhm
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Drexler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Hasenfuß
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Lemke
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Osterspey
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Pauschinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoppe, U., Böhm, M., Drexler, H. et al. Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008. Kardiologe 3, 16–23 (2009). https://doi.org/10.1007/s12181-008-0146-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-008-0146-1

Schlüsselwörter

Keywords

Search

Navigation